![PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis](https://www.researchgate.net/publication/328404687/figure/fig1/AS:866550177361920@1583613070537/LS-mean-LOS-by-treatment-group-for-index-event-adjusted-for-cancer-at-baseline-PMS_Q320.jpg)
PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis
![Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR](https://bmjopen.bmj.com/content/bmjopen/10/9/e038012/F1.large.jpg)
Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR
Copyright © and Moral Rights for this thesis are retained by the author and/or other copyright owners. A copy can be downloaded
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
![Architecture as an object of diary: Nostalgia evoked through embodied memory by Alex Antoniou - Issuu Architecture as an object of diary: Nostalgia evoked through embodied memory by Alex Antoniou - Issuu](https://image.isu.pub/110309003038-07e608506ee5430e96dc6dead82c6f6b/jpg/page_1.jpg)
Architecture as an object of diary: Nostalgia evoked through embodied memory by Alex Antoniou - Issuu
![PDF) Rationale and design of XAMOS: Noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery PDF) Rationale and design of XAMOS: Noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery](https://i1.rgstatic.net/publication/225372399_Rationale_and_design_of_XAMOS_Noninterventional_study_of_rivaroxaban_for_prophylaxis_of_venous_thromboembolism_after_major_hip_and_knee_surgery/links/0a85e52d5b9175d8c5000000/largepreview.png)
PDF) Rationale and design of XAMOS: Noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
![PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis](https://i1.rgstatic.net/publication/328404687_Healthcare_resource_use_in_XALIA_A_subgroup_analysis_of_a_non-interventional_study_of_rivaroxaban_versus_standard_anticoagulation_for_deep_vein_thrombosis/links/5e6403ed92851c7ce04ef02c/largepreview.png)
PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis
![newplan χαλια κρεβατοκαμαρας (σετ 3τμχ) new plan lily 66 grey - Σετ Χαλιά Κρεβατοκάμαρας - Shopistas newplan χαλια κρεβατοκαμαρας (σετ 3τμχ) new plan lily 66 grey - Σετ Χαλιά Κρεβατοκάμαρας - Shopistas](https://cdna.shopistas.gr/vpimgs/1/1/d/8/4/4/1609831_newplan-xalia-krebatokamaras-set-3tmx-new-plan-lily-66-grey.webp)
newplan χαλια κρεβατοκαμαρας (σετ 3τμχ) new plan lily 66 grey - Σετ Χαλιά Κρεβατοκάμαρας - Shopistas
![PDF) Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial PDF) Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial](https://www.researchgate.net/publication/333339473/figure/fig1/AS:761995460608003@1558685283864/Flow-diagram-of-the-screening-selection-and-enrolment-process-PE-pulmonary-embolism_Q320.jpg)